Royal Bank Of Canada Cumberland Pharmaceuticals Inc Transaction History

Royal Bank Of Canada

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$1.68 - $2.24 $152 - $203	-91 Reduced 65.94%	47 $0
Q4 2023 Feb 14, 2024	SELL	$1.6 - $2.14 $16 - $21	-10 Reduced 6.76%	138 $0
Q3 2023 Nov 14, 2023	SELL	$1.43 - $2.3 $233 - $374	-163 Reduced 52.41%	148 $0
Q2 2023 Aug 14, 2023	BUY	$1.47 - $2.01 $457 - $625	311 New	311 $0

1.97M

44.2K

Ticker CPIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 14,661,900
Market Cap $33.3M
Description
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.